Prostaglandin D Synthase (lipocalin-type; human recombinant)

Prostaglandin D Synthase (lipocalin-type; human recombinant)
Artikelnummer
CAY10006788
Verpackungseinheit
250 µg
Hersteller
Cayman Chemical

Verfügbarkeit: wird geladen...
Preis wird geladen...
Formulation: 50 mM sodium phosphate, pH 7.2, containing 20% glycerol, 150 mM sodium chloride, 1 mM DTT, and 0.5 mM EDTA

Purity: ≥85% estimated by SDS-PAGE

Shelf life (days): 730

Notes: Prostaglandin D synthase (PGDS) catalyzes the isomerization of PGH2 to produce PGD2. PGD2 induces sleep, regulates nociception, inhibits platelet aggregation, and acts as an allergic mediator. Two distinct types of PGDS have been identified, namely the lipocalin-type enzyme and the hematopoietic enzyme.{8448,9588,12044} L-PGDS is localized in the central nervous system and male genital organs of various mammals and the human heart. This enzyme has been identified as β-trace, which is a major protein in human cerebrospinal fluid.{8448} Cayman’s L-PGDS (human recombinant) is a highly-purified GST-fusion protein isolated from an E. coli expression system. Cysteines 89 and 186 have been changed to alanines to prevent protein misfolding.
Mehr Informationen
Artikelnummer CAY10006788
Hersteller Cayman Chemical
Hersteller Artikelnummer 10006788-250
Green Labware Nein
Verpackungseinheit 250 µg
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF) Download